IGF2BP2 and cancer: The enhanced mRNA stability leads to persistent AR‐V7 expression inside cells, thereby contributing to CRPC progression and enzalutamide resistance, in line with previous studies demonstrating the role of IGF2BP2 in regulating cancer progression by stabilizing various mRNA and lncRNA transcripts [39, 40, 41].